- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Plasma Cell Disorder in United Kingdom
Total 71293 results
-
Senesco Technologies, Inc.UnknownMultiple Myeloma | Plasma Cell Leukemia | Multiple Myeloma in Relapse | Mantle Cell Lymphoma in Relapse | Diffuse Large B Cell Lymphoma in Relapse | Other B Cell Lymphoma in RelapseUnited States, South Africa
-
National Cancer Institute (NCI)CompletedMyeloma-Multiple | Myeloma, Plasma-CellUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedMultiple Myeloma | Leukemia, Plasma CellUnited States
-
CelgeneCompletedMultiple MyelomaUnited Kingdom, France
-
University of California, San FranciscoCompletedRefractory Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Plasma Cell Myeloma | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | Recurrent High Grade B-Cell Lymphoma | Refractory High Grade B-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedPolycythemia Vera | Essential Thrombocythemia | Chronic Myeloproliferative Disorders | Multiple Myeloma | Myelofibrosis | Chronic Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Prolymphocytic Leukemia | Plasma Cell Leukemia | Small Lymphocytic Lymphoma and other conditionsUnited States
-
Oxford University Hospitals NHS TrustAmgenCompletedMyeloma | Smouldering Myeloma | Monoclonal Gammopathy of Undetermined Significance (MGUS)United Kingdom
-
Chroma TherapeuticsCompletedAcute Myeloid Leukemia | Multiple Myeloma | Myelodysplastic SyndromeUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Anemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationActive, not recruitingPlasma Cell Myeloma | Residual DiseaseUnited States
-
University of Colorado, DenverTerminatedRefractory Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterActive, not recruitingPlasma Cell Myeloma | Transplant-Related CarcinomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); National...CompletedLymphoma | Plasma Cell MyelomaUnited States
-
Thomas Jefferson UniversityCompletedPlasma Cell MyelomaUnited States
-
SanofiCompletedPlasma Cell MyelomaUnited States
-
King's College Hospital NHS TrustCompleted
-
University of RochesterCompletedMultiple Myeloma and Plasma Cell Neoplasm | Drug/Agent Toxicity by Tissue/OrganUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedLymphoma | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingPlasma Cell MyelomaUnited States
-
Emory UniversityCompleted
-
National Cancer Institute (NCI)CompletedMultiple Myeloma | Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Lymphoma | Leukemia | Plasma Cell Myeloma | B-Cell Non-Hodgkin Lymphoma | T-Cell Non-Hodgkin LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
OnxeoCompletedMultiple MyelomaUnited States, Denmark, United Kingdom, Norway
-
The Cleveland ClinicNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Precancerous/Nonmalignant Condition | Secondary Myelofibrosis | Multiple Myeloma and Malignant Plasma Cell NeoplasmsUnited States
-
National Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingPlasma Cell MyelomaUnited States
-
Jason ValentCompletedMultiple Myeloma | Kahler Disease | Myelomatosis | Plasma-Cell MyelomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Incyte CorporationRecruitingMyelodysplastic Syndromes | Myeloproliferative Disorders | Multiple Myeloma | Plasma Cell Leukemia | CML | T-cell Prolymphocytic Leukemia | Leukemia, Acute | Myelomonocytic Leukemia, ChronicUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Plasma Cell MyelomaUnited States
-
Srinivas DevarakondaTerminatedRecurrent Plasma Cell MyelomaUnited States
-
Ohio State University Comprehensive Cancer CenterCelgeneCompletedRecurrent Plasma Cell MyelomaUnited States
-
California Cancer ConsortiumNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of Maryland, BaltimoreCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of Maryland, BaltimoreCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of ChicagoNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
The Cleveland ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma | Anemia | Plasma Cell NeoplasmUnited States
-
University of LeedsCompletedRelapsed or Refractory Multiple MyelomaUnited Kingdom
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited Kingdom, United States, France, Netherlands, Denmark
-
Washington University School of MedicineNational Cancer Institute (NCI)TerminatedLymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
SanofiRecruitingPlasma Cell MyelomaGermany, United States, Argentina, China, France, Hong Kong, Italy, Japan, Puerto Rico, Spain, Switzerland, United Arab Emirates, United Kingdom, Austria, Belgium, Netherlands, Taiwan